Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 2;14(3):e1002372.
doi: 10.1371/journal.pbio.1002372. eCollection 2016 Mar.

Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?

Glenda E Gray  1   2 , Fatima Laher  2 , Tanya Doherty  1   3   4 , Salim Abdool Karim  5   6 , Scott Hammer  7 , John Mascola  8 , Chris Beyrer  9   10 , Larry Corey  11
Affiliations
Review

Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?

Glenda E Gray et al. PLoS Biol. .

Erratum in

Abstract

In the last 15 years, antiretroviral therapy (ART) has been the most globally impactful life-saving development of medical research. Antiretrovirals (ARVs) are used with great success for both the treatment and prevention of HIV infection. Despite these remarkable advances, this epidemic grows relentlessly worldwide. Over 2.1 million new infections occur each year, two-thirds in women and 240,000 in children. The widespread elimination of HIV will require the development of new, more potent prevention tools. Such efforts are imperative on a global scale. However, it must also be recognised that true containment of the epidemic requires the development and widespread implementation of a scientific advancement that has eluded us to date--a highly effective vaccine. Striving for such medical advances is what is required to achieve the end of AIDS.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Medical interventions required to end the epidemic of HIV.
Image credit: Glenda Gray.
Fig 2
Fig 2. The spectrum of biomedical innovation required to end AIDS.
Image credit: Glenda Gray.
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention. HIV Surveillance Report Volume 24: 2012. 2012.
    1. UNAIDS. The Gap Report 2013. Geneva: UNAIDS, 2014.
    1. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57. Epub 2008/11/29. 10.1016/S0140-6736(08)61697-9 . - DOI - PubMed
    1. World Health Organisation. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV Geneva: WHO, 2015. - PubMed
    1. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. The Lancet. 370(9583):251–61. 10.1016/S0140-6736(07)60950-7 - DOI - PMC - PubMed

Publication types